NanoVibronix, Inc. (NAOV)
NASDAQ: NAOV · Real-Time Price · USD
6.97
-0.68 (-8.89%)
Sep 17, 2025, 2:32 PM EDT - Market open
NanoVibronix Market Cap
NanoVibronix has a market cap or net worth of $5.56 million as of September 17, 2025. Its market cap has increased by 247.70% in one year.
Market Cap
5.56M
Enterprise Value
4.19M
1-Year Change
247.70%
Ranking
Category
Stock Price
$6.97
Market Cap Chart
Since May 28, 2015, NanoVibronix's market cap has decreased from $6.43B to $5.56M, a decrease of -99.91%. That is a compound annual growth rate of -49.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 6.10M | 175.40% |
| Dec 31, 2024 | 2.21M | -5.92% |
| Dec 29, 2023 | 2.35M | -71.52% |
| Dec 30, 2022 | 8.26M | -97.82% |
| Dec 31, 2021 | 379.13M | -91.52% |
| Dec 31, 2020 | 4.47B | -76.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |